High circulating N-terminal pro-B-type natriuretic peptide is associated with greater systolic cardiac dysfunction and nonresponsiveness to fluids in septic vs nonseptic critically ill patients

Journal of Critical Care

Volumn 26, Issue 1, 2011, Pages 108.e1-108.e8

  Hartemink, Koen J ^a,b   Twisk, Jos W R ^b   Groeneveld, A B Johan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Critically ill; Fluid responsiveness; NT proBNP; Septic shock; Systolic cardiac function

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; COLLOID; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DIASTOLE; FEMALE; FLUID THERAPY; HUMAN; INTENSIVE CARE UNIT; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SEPSIS; SEPTIC SHOCK; SYSTOLE; SYSTOLIC DYSFUNCTION; THERMODILUTION; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; WATER LOADING;

EID: 79551551959     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2010.05.002     Document Type: Article

References (36)

1. Daniels L.B., Maisel A.S. Natriuretic peptides. J Am Coll Cardiol 2007, 50:2357-2368.
2. Maisel A., Mueller C., Adams K., et al. State of the art: using natriuretic peptide levels in clinical practise. Eur J Heart Fail 2008, 19:824-839.
3. Jefic D., Lee J.W., Jefic D., et al. Utility of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients. Chest 2000, 128:288-295.
4. McLean A.S., Huang S.J., Nalos M., et al. The confounding effect of age, gender, creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med 2003, 31:2611-2617.
5. Forfia P.R., Watkins S.P., Rame E., et al. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 2005, 45:1667-1671.
6. Rudiger A., Gasser S., Fischler M., et al. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 2006, 34:2140-2144.
7. Rana R., Vlahakis N.E., Daniels C.E., et al. B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema. Crit Care Med 2006, 34:1941-1946.
8. Januzzi J.L., Morss A., Tung R., et al. Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study. Crit Care 2006, 10:R37.
9. Mekontso-Dessap A., Tual L., Kirsch M., et al. B-type natriuretic peptide to assess haemodynamic status after cardiac surgery. Br J Anaesth 2006, 97:777-782.
10. Bal L., Thierry S., Brocas E., et al. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress. Acta Anaesthesiol Scand 2006, 50:340-347.
11. Provenchère S., Berroeta C., Reynaud C., et al. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 2006, 34:995-1000.
12. Maeder M., Fehr T., Rickli H., et al. Sepsis-associated myocardial dysfunction diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006, 129:1349-1366.
13. Shah K.B., Nolan M.M., Rao K., et al. The characteristics and prognostic importance of NT-proBNP concentrations in critically ill patients. Am J Med 2007, 120:1071-1077.
14. Rivers E.P., McCord J., Otero R., et al. Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock. J Intensive Care Med 2007, 22:363-373.
15. Stewart D., Waxman K., Brown A., et al. B-type natriuretic peptide levels may be elevated in the critically injured trauma patients without congestive heart failure. J Trauma 2007, 63:747-750.
16. McLean A.S., Huang S.J., Hyams S., et al. Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007, 35:1019-1026.
17. Wolff B., Haase D., Lazarus P., et al. Severe septic inflammation as a strong stimulus of myocardial NT-pro brain natriuretic peptide release. Intern J Cardiol 2007, 122:131-136.
18. Varpula M., Pulkki K., Karlsson S., et al. for the FINNSEPSIS Study Group. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007, 35:1277-1283.
19. Kandil E., Burack J., Sawas A., et al. B-type natriuretic peptide. A biomarker for the diagnosis and risk stratification of patients with septic shock. Arch Surg 2008, 143:242-246.
20. Ueda S., Nishio K., Akai Y., et al. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock. Shock 2006, 26:134-139.
21. Witthaut R., Busch C., Fraunberger P., et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis associated left ventricular dysfunction. Intensive Care Med 2003, 29:1696-1702.
22. Hoffmann U., Brueckmann M., Bertsch T., et al. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin Lab 2005, 51:373-379.
23. Shor R., Rozenman Y., Bolshinsky A., et al. BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med 2006, 17:536-540.
24. Pirracchio R., Deye N., Lukaszewicz A.C., et al. Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med 2008, 36:2542-2546.
25. Charpentier J., Luyt C.E., Fulla Y., et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004, 32:660-665.
26. Brueckmann M., Huhle G., Lang S., et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005, 112:527-534.
27. Roch A., Allardet-Servent J., Michelet P., et al. NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 2005, 33:1001-1007.
28. Meyer B., Huelsmann M., Wexberg P., et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med 2007, 35:2268-2273.
29. Almog Y., Novack V., Megralishvili R., et al. Plasma level of N terminal pro-brain natriuretic peptide as a prognostic marker in critically ill patients. Anesth Analg 2006, 102:1809-1815.
30. Michard F., Alaya S., Zarka V., et al. Global end-diastolic volume as an indicator of cardiac preload in patients with septic shock. Chest 2003, 124:1900-1908.
31. Bouhemad B., Nicolas-Robin A., Arbelot C., et al. Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med 2009, 37:441-447.
32. Combes A., Berneau J.B., Luyt C.E., et al. Estimation of left ventricular systolic function by single transpulmonary thermodilution. Intensive Care Med 2004, 30:1377-1383.
33. Verheij J., van Lingen A., Beishuizen A., et al. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med 2006, 32:1030-1038.
34. Royse C.F., Connelly K.A., MacLaren G., et al. Evaluation of echocardiography indices of systolic function: a comparative study using pressure-volume loops in patients undergoing coronary artery bypass surgery. Anaesthesia 2007, 62:109-116.
35. Johansen L.B., Bie P., Warberg J., et al. Hemodilution, central blood volume, and renal responses after an isotonic saline infusion in humans. Am J Physiol 1997, 272:R549-R556.
36. Kumar A., Anel R., Bunnell E., et al. Preload-independent mechanisms contribute to increased stroke volume following large volume saline infusion in normal volunteers: a prospective interventional study. Crit Care 2004, 8:R128-R136.